TrialClinical and translational science2026

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Oral TYK2 Inhibitor D-2570 in Healthy Subjects: A First-in-Human Phase I Study.

Meng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.